Conclusion
In conclusion, we could confirm the expression of CGA in the equine submandibular gland. We consider that the salivary level as well as the plasma level of the CGA-LI can be a quantitative index for monitoring the activity of the sympathetic nervous system in physical and psychological stress of race horses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aunis, D., Goumon, Y., Lugardon, K., and Metz-Boutigue, M.H., 1998, Antibacterial peptides in chromaffine cell secretory granules. In: The Adrenal Chromaffin Cell: Archetype and Exemplar of Cellular Signalling in Secretory Control, (T. Kanno, Y. Nakazato, and K. Kumakura, eds, Hokkaido University Press, Sapporo, pp. 293–304.
Frohman, M. A. 1994. PCR Methods Appl. 4: S40–58.
Iacangelo, A.L., and Eiden, L.E., 1995, Chromogranin A current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway. Regul. Pept. 58: 65–88.
Iacangelo, A., Affolter, H., Eiden, L., Herbert, E., and Grimes, M., 1986, Bovine chromogranin A: its sequence and the distribution of its messenger RNA in tissues. Nature (London) 323: 82–86.
Iacangelo, A., Okayama, H., and Eiden, L.E. 1988, Primary structure of rat chromogranin A and distribution ofits mRNA. FEBS Lett. 227: 115–121.
Iacangelo, A.L., Fischer-Colbrie, R., Koller, K.J., Brownstein, M.J., and Eiden, L.E., 1988, The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology 122: 2339–2341.
Konecki, D.S., Benedum, U.M., Gerdes, H.H., and Huttner, W.B., 1987, The primary structure ofhuman chromogranin A and pancreastatin. J. Biol. Chem. 262: 17026–17030.
Mahata, S.K., O’Connor, D.T., Mahata, M., Yoo, S.H., Taupenot, L., Wu, H., Gill, B.M., and Parmer, R.J., 1997, Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J. Clin. Invest. 100: 1623–1633.
Metz-Boutigue, M.H., Goumon, Y., Lugardon, K., Strub, J.M., and Aunis, D., 1998, Antibacterial peptides are present in chromaffin cell secretory granules. Cell. Mol. Neurobiol. 18: 249–266.
Mouland, A.J., Bevan, S., White, J.H., and Hendy, G.N., 1994, Human Chromogranin A Gene. J. Biol. Chem. 269: 6918–6926.
Nishikawa, Y., Nagasawa, S., Yanaihara, N., Iguchi, K., Mochizuki, T., Hoshino, M., Iwanaga, T., and Yanaihara, C., 1998, Immunoreactive chromogranin A in rat plasma and urine measured by region-specific radioimmunoassay. Biomed. Res. 19: 237–244.
Tatemoto, K., Efendic, S., Mutt, V., Makk, G., Feistner, G.J., and Barchas, J.D., 1986, Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (London) 324: 476–478.
Turquier, V., Vaudry, H., Jegou, S., and Anouar, Y., 1999, Frog chromogranin A messenger ribonucleic acid encodes three highly conserved peptides. Coordinate regulation of proopiomelanocortin and chromogranin A gene expression in the pars intermedia of the pituitary during background color adaptation. Endocrinology 140: 4104–4112.
Winkler, H., and Fischer-Colbrie, R., 1992, The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49: 497–528.
Wu, H.J., Rozansky, D.J., Parmer, R.J., Gill, B.M., and O’Connor, D.T., 1991, Structure and function ofthe chromogranin A gene. J. Biol. Chem. 266: 13130–13134.
Yanaihara, H., Hata, M., Nishikawa, Y., Hoshino, M., Yanaihara, N., and Murai, M., 1999, Application of region specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma. Regul. Pept. 80: 83–90.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sato, F. et al. (2002). Expression of Equine Chromogranin A. In: Helle, K.B., Aunis, D. (eds) Chromogranins. Advances in Experimental Medicine and Biology, vol 482. Springer, Boston, MA. https://doi.org/10.1007/0-306-46837-9_10
Download citation
DOI: https://doi.org/10.1007/0-306-46837-9_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46446-1
Online ISBN: 978-0-306-46837-7
eBook Packages: Springer Book Archive